SD-ICU: Feasibility Study of Cortical Recording Depolarizations in Brain-injured Patients, and Their Use as Biomarkers of New Lesions.

Sponsor
Hospices Civils de Lyon (Other)
Overall Status
Recruiting
CT.gov ID
NCT04585503
Collaborator
(none)
20
1
1
30.9
0.6

Study Details

Study Description

Brief Summary

The progression of brain lesions after severe head trauma or subarachnoid hemorrhage results from extra cranial aggression which is well controlled in intensive care and intracranial aggression which is less well known and therefore less well managed. The detection of events that can generate new lesions from intracranial monitoring is limited and late once the lesions are irreversible. Invasive cortical depolarizations (SD) can be observed using cortical electrodes and an acquisition system having access to the usually filtered DC signal (0 to 1 Hz). SD are observed at the onset of a new attack of the cortex and spread widely away from the site of aggression. During their propagation, SD generate a significant metabolic demand, and can cause ischemic injury, particularly after meningeal or post-traumatic hemorrhage. SDs are therefore both a marker of new lesion and a mechanism of progression of primary lesions. Yet this type of monitoring is only performed in some expert centers around the world. The analysis of the feasibility and safety of the placement of cortical electrodes in this indication is therefore an essential step to study the clinical benefit of individualized management on the basis of this monitoring.

Condition or Disease Intervention/Treatment Phase
  • Device: Electrode implantation
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Feasibility Study of Cortical Recording Depolarizations in Brain-injured Patients, and Their Use as Biomarkers of New Lesions.
Actual Study Start Date :
Jan 1, 2021
Anticipated Primary Completion Date :
Aug 1, 2023
Anticipated Study Completion Date :
Aug 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Central nervous system monitoring

Each 20 patients will be implanted with subdural or intra cortical electrodes

Device: Electrode implantation
The intervention consist in implanting 6 electrodes in subdural or intra cortical position and monitor the central nervous system activity. This monitoring will be additional to the usual monitoring.

Outcome Measures

Primary Outcome Measures

  1. Evaluation of Invasive cortical depolarization (SD) recorded in a non-expert center with subdural or intra cortical implanted electrode and central nervous system monitoring. [18 months]

    The feasibility of the study will be objectivized by the availability of a signal of sufficient quality to be exploited, with or without SD: namely a signal without artifact on more than 30% of the recording period on at least 3 electrodes on 6 for at least 12h. The signal analysis should, at least twice a day, allow intervening with the patient if necessary.

Secondary Outcome Measures

  1. Evaluation of electrode implantation safety [during implantation procedure]

    Safety will be evaluated recording severe and non-severe adverse events during implantation procedure.

  2. Evaluation of electrode implantation safety [during monitoring, maximum 15 days]

    Safety will be evaluated recording severe and non-severe adverse events during monitoring

  3. Evaluation of electrode implantation safety. [during electrode extraction]

    Safety will be evaluated recording severe and non-severe adverse events during electrode extraction.

  4. Evaluation of temporality between Invasive cortical depolarization and intracranial hypertension. [during monitoring, maximum 15 days]

    proportion of patient with Invasive cortical depolarization before, during and after intracranial hypertension.

  5. Evaluation of temporality between Invasive cortical depolarization and oxygen in tissue decreasing pressure [during monitoring, maximum 15 days]

    proportion of patient with Invasive cortical depolarization before during and after oxygen in tissue decreasing.

  6. Evaluation of temporality between Invasive cortical depolarization and detection of a vasospasm [during monitoring, maximum 15 days]

    proportion of patient with Invasive cortical depolarization before during and after detection of a vasospasm.

  7. Evaluation of temporality between Invasive cortical depolarizations and EEG change of rhythm. [during monitoring, maximum 15 days]

    proportion of patient with Invasive cortical depolarization before, during and after EEG change of rhythm.

  8. Evaluation of temporality between Invasive cortical depolarization and detection of a new cerebral lesion. [during monitoring, maximum 15 days]

    proportion of patient with Invasive cortical depolarization before, during and after detection of a new cerebral lesion.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient > 18 year old

  • Patients admitted in neurological reanimation unit for brain lesions after severe head trauma or subarachnoid hemorrhage and requesting a intracranial monitoring or a surgery (evacuation of a hematoma, treatment of an aneurysm, external ventricular bypass).

  • Patients affiliated to a social security system

  • Patient having been informed and having signed the Consent form OR Close to the patient who has been informed and signed the Consent form OR third party certificate then close consent for further study.

Exclusion Criteria:
  • Patient with scalp acute infection

  • Pregnant or nursing women

  • Contre-indication to intracranial surgery

  • Patient with not corrected coagulation disorder

  • Patient treated with NSAIDS

  • Patient treated with under platelet antiaggregants

  • Patient under legal protection, guardianship, curators

  • patients under legal protection

  • Patient participating in a study who may interfere with this study.

  • people under duress psychiatric care,

Contacts and Locations

Locations

Site City State Country Postal Code
1 Service d'Anesthésie réanimation Groupement hospitalier Est, hôpital Pierre Wertheimer Bron France 69500

Sponsors and Collaborators

  • Hospices Civils de Lyon

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hospices Civils de Lyon
ClinicalTrials.gov Identifier:
NCT04585503
Other Study ID Numbers:
  • 69HCL19_0615
First Posted:
Oct 14, 2020
Last Update Posted:
Jul 7, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hospices Civils de Lyon
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 7, 2022